We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+25.61%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$147M
AUM Growth
+$17M
Cap. Flow
-$7.21M
Cap. Flow %
-4.9%
Top 10 Hldgs %
40.47%
Holding
58
New
7
Increased
9
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$3.96M
2
PARA
Paramount Global Class B
PARA
+$3.41M
3
ADBE icon
Adobe
ADBE
+$3.24M
4
META icon
Meta Platforms (Facebook)
META
+$2.91M
5
OKTA icon
Okta
OKTA
+$1.6M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$5M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.43M
3
SNPS icon
Synopsys
SNPS
+$4.12M
4
TWLO icon
Twilio
TWLO
+$4M
5
AMT icon
American Tower
AMT
+$3.1M

Sector Composition

Rank Sector Weight
1 Technology 34.99%
2 Consumer Discretionary 19.86%
3 Healthcare 16.1%
4 Communication Services 15.35%
5 Financials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$683B
$2.42M 1.65%
12,900
– –
ADMA icon
27
ADMA Biologics
ADMA
$2.03B
$2.4M 1.63%
600,000
+50,000
+9% +$218K
RETA
28
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.04M 1.39%
+10,000
New +$1.82M
UNH icon
29
UnitedHealth
UNH
$377B
$2.03M 1.38%
6,900
+1,500
+28% +$392K
MA icon
30
Mastercard
MA
$500B
$1.94M 1.32%
6,500
– –
MDT icon
31
Medtronic
MDT
$111B
$1.7M 1.16%
15,000
– –
ILMN icon
32
Illumina
ILMN
$30B
$1.66M 1.13%
5,140
– –
TMO icon
33
Thermo Fisher Scientific
TMO
$213B
$1.62M 1.1%
5,000
– –
ESPR
34
DELISTED
Esperion Therapeutics
ESPR
$1.19M 0.81%
+20,000
New +$899K
HRTX icon
35
Heron Therapeutics
HRTX
$96.8M
$1.18M 0.8%
50,000
+11,000
+28% +$243K
AGIO icon
36
Agios Pharmaceuticals
AGIO
$1.82B
$1M 0.68%
+21,000
New +$794K
NBIX icon
37
Neurocrine Biosciences
NBIX
$16.7B
$967K 0.66%
+9,000
New +$942K
LH icon
38
Labcorp
LH
$24.9B
$947K 0.64%
6,518
– –
AZN icon
39
AstraZeneca
AZN
$245B
$643K 0.44%
6,450
– –
JPM icon
40
JPMorgan Chase
JPM
$937B
$638K 0.43%
4,575
– –
CRSP icon
41
CRISPR Therapeutics
CRSP
$4.88B
$609K 0.41%
10,000
– –
TXMD icon
42
TherapeuticsMD
TXMD
$23.6M
$605K 0.41%
5,000
+2,760
+123% +$397K
MRK icon
43
Merck
MRK
$316B
$568K 0.39%
6,540
– –
MGP
44
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$534K 0.36%
17,250
-15,000
-47% -$461K
BA icon
45
Boeing
BA
$185B
$489K 0.33%
1,500
– –
BP icon
46
BP
BP
$114B
$473K 0.32%
12,532
– –
RDS.B
47
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$467K 0.32%
7,792
– –
EDIT icon
48
Editas Medicine
EDIT
$407M
$444K 0.3%
15,000
– –
VICI icon
49
VICI Properties
VICI
$29.2B
$440K 0.3%
17,230
-32,000
-65% -$774K
CLLS
50
Cellectis
CLLS
$277M
$291K 0.2%
17,000
– –
1
2
3

Similar funds

SPW
Sonoma Private Wealth Sonoma, California $81.2M AUM 22.25% 1-Year Est. Return
MC
Medici Capital Newport Beach, California $81.2M AUM 76.04% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $81.1M AUM
BCM
Beaumont Capital Management Boston, Massachusetts $81M AUM 17.14% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
AGFVA
Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return
HM
HCEP Management Hong Kong $80.7M AUM 1.24% 1-Year Est. Return
FWS
FinDec Wealth Services Stockton, California $81.8M AUM 13.5% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Morgens Waterfall Vintiadis & Co held 58 positions worth $147M, up 13% from $130M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $7.21M in Q4 2019, closing 8 positions and reducing 8 holdings. Its most notable exit was McDonald's, an estimated $5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in Caesars Entertainment worth $4.77M.

  • Morgens Waterfall Vintiadis & Co's largest Q4 2019 buy was Caesars Entertainment: 80,000 shares worth $4.77M.
  • Morgens Waterfall Vintiadis & Co added most to Adobe in Q4 2019, an estimated $3.24M increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $1.71M.
  • Morgens Waterfall Vintiadis & Co fully exited McDonald's in Q4 2019, selling an estimated $5M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 40% of its $147M portfolio in Q4 2019.
  • Morgens Waterfall Vintiadis & Co opened 7 new positions and closed 8 in Q4 2019.
  • Morgens Waterfall Vintiadis & Co's portfolio value rose 13% quarter-over-quarter to $147M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2019, filed 14 Feb 2020.